Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.

The Journal of Clinical Investigation
Damien BressonMatthias von Herrath

Abstract

Safe induction of autoantigen-specific long-term tolerance is the "holy grail" for the treatment of autoimmune diseases. In animal models of type 1 diabetes, oral or i.n. immunization with islet antigens induces Tregs that are capable of bystander suppression. However, such interventions are only effective early in the prediabetic phase. Here, we demonstrate that a novel combination treatment with anti-CD3epsilon-specific antibody and i.n. proinsulin peptide can reverse recent-onset diabetes in 2 murine diabetes models with much higher efficacy than with monotherapy with anti-CD3 or antigen alone. In vivo, expansion of CD25(+)Foxp3(+) and insulin-specific Tregs producing IL-10, TGF-beta, and IL-4 was strongly enhanced. These cells could transfer dominant tolerance to immunocompetent recent-onset diabetic recipients and suppressed heterologous autoaggressive CD8 responses. Thus, combining a systemic immune modulator with antigen-specific Treg induction is more efficacious in reverting diabetes. Since Tregs act site-specifically, this strategy should also be expected to reduce the potential for systemic side effects.

References

Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·L ChatenoudJ F Bach
Feb 13, 1996·Annals of the New York Academy of Sciences·D Daniel, D R Wegmann
Jul 20, 1999·The Journal of Clinical Investigation·B CoonM G von Herrath
Nov 28, 2001·Immunological Reviews·L ChatenoudJ A Bluestone
May 31, 2002·The New England Journal of Medicine·Kevan C HeroldJeffrey A Bluestone
Jul 3, 2002·Endocrinology and Metabolism Clinics of North America·Edwin Liu, George S Eisenbarth
Feb 4, 2003·Nature Reviews. Immunology·Lucienne Chatenoud
Feb 6, 2003·The Journal of Clinical Investigation·Kevan C HeroldJeffrey A Bluestone
May 3, 2003·The Journal of Clinical Investigation·Nathan R MartinezLeonard C Harrison
Jun 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Scott M LiebermanTeresa P DiLorenzo
Jan 30, 2004·Nature Immunology·Cathryn Nagler-AndersonCox Terhorst
Jun 9, 2004·The Journal of Experimental Medicine·Kristin V TarbellRalph M Steinman
Nov 3, 2004·The Journal of Clinical Investigation·Urs ChristenMatthias G von Herrath
Dec 25, 2004·Infection and Immunity·Anna LundgrenB Samuel Lundin
Mar 18, 2005·Annual Review of Immunology·Mark S Anderson, Jeffrey A Bluestone
Apr 7, 2005·Nature Medicine·Mark Larché, David C Wraith
Jun 24, 2005·The New England Journal of Medicine·Bart KeymeulenLucienne Chatenoud
Jul 15, 2005·Nature Medicine·David M Harlan, Matthias von Herrath
Sep 17, 2005·The Journal of Clinical Investigation·Brygida BisikirskaKevan C Herold

❮ Previous
Next ❯

Citations

Jun 11, 2008·Immunologic Research·Bo Wang, Roland Tisch
Dec 5, 2008·Immunologic Research·Bo Wang, Roland Tisch
Aug 20, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Damien BressonMatthias von Herrath
Sep 20, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Wilhem LeconetDamien Bresson
May 1, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Jennifer SherrKevan C Herold
Jun 2, 2011·Nature Reviews. Drug Discovery·Frank Waldron-Lynch, Kevan C Herold
Feb 23, 2010·Nature Reviews. Endocrinology·Lucienne Chatenoud
Jul 21, 2007·Nature Reviews. Immunology·Lucienne Chatenoud, Jeffrey A Bluestone
Nov 6, 2007·Nature Reviews. Immunology·Matthias von HerrathKevan Herold
Jan 26, 2010·Nature Reviews. Immunology·Bart O Roep, Mark Peakman
Oct 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Maria KoulmandaTerry B Strom
Jan 4, 2007·The Journal of Experimental Medicine·Suchita NadkarniMichael R Ehrenstein
Nov 23, 2006·The Journal of Experimental Medicine·Brian T FifeJeffrey A Bluestone
Jan 11, 2007·The Journal of Experimental Medicine·Kristin V TarbellRalph M Steinman
Aug 4, 2010·The Journal of Experimental Medicine·Junko NishioChristophe Benoist
Nov 26, 2011·Journal of Molecular Cell Biology·Cheng-Rui LiLinda M Bradley
May 14, 2010·Rheumatology·Ellen J WehrensBerent J Prakken
Feb 23, 2012·Cold Spring Harbor Perspectives in Medicine·Xavier Clemente-CasaresPere Santamaria
Mar 7, 2012·Cold Spring Harbor Perspectives in Medicine·Lukas T JekerJeffrey A Bluestone
Feb 4, 2011·Science Translational Medicine·Chantal KuhnLucienne Chatenoud
Feb 4, 2011·Science Translational Medicine·Damien Bresson, Matthias von Herrath
Aug 19, 2011·Science Translational Medicine·Mark A Atkinson
Sep 22, 2006·Annual Review of Medicine·E William St ClairJeffrey Bluestone
Jul 26, 2011·Clinical & Developmental Immunology·Brett PhillipsNick Giannoukakis
Aug 12, 2008·Investigative Ophthalmology & Visual Science·Pranita P SarangiBarry T Rouse
Sep 6, 2007·The Journal of Clinical Investigation·Tomer NirYuval Dor
Apr 24, 2008·The Journal of Clinical Investigation·Tom Van Belle, Matthias von Herrath
May 8, 2009·The Journal of Clinical Investigation·Matthias von Herrath, Andrew Chan
May 30, 2009·The Journal of Clinical Investigation·Christophe M FilippiMatthias G von Herrath
Sep 17, 2009·Journal of Immune Based Therapies and Vaccines·Rubens R SantosCélio L Silva
May 19, 2012·PloS One·Maria KoulmandaTerry B Strom
Jan 1, 2012·The Review of Diabetic Studies : RDS·Mario R Ehlers, Gerald T Nepom
Jan 1, 2012·The Review of Diabetic Studies : RDS·Lucienne Chatenoud, Herman Waldmann
Dec 21, 2006·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Matthias von HerrathDamien Bresson
Nov 8, 2011·Immunotherapy·Ben SprangersChantal Mathieu

❮ Previous
Next ❯

Methods Mentioned

BETA
lymphodepletion
RIP
PCR
PMA
ELISA

Software Mentioned

Softmax Pro

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.